How do you treat clear cell renal cell carcinoma with metastatic recurrence while on adjuvant pembrolizumab?   

Would you consider using an IO-based treatment or move on to TKI? Does the presence of sarcomatoid or rhabdoid features impact your approach?



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution